International Clinical Trial: Trial Phase: Syndemic Adapted Medly Uganda

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525271) titled 'Trial Phase: Syndemic Adapted Medly Uganda' on April 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Yale University

Condition: Mental Health

Intervention: Device: Syndemic-Adapted Medly Uganda (SAMU)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: June 2026

Target Sample Size: 1500

Countries of Recruitment: Uganda

To know more, visit https://clinicaltrials.gov/study/NCT07525271

Published by HT Digital Content Services with permission from Heal...